Back
87
Also listed as
ICAGY
OTC
Day Range
$4.70
$5.20
52-Week Range
$2.90
$6.00
Volume
600
50D / 200D Avg
$5.58
/
$5.19
Prev Close
$4.70
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (894 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 6.5 | 14.4 |
| P/B | 2.8 | 1.9 |
| ROE % | 47.7 | 11.4 |
| Net Margin % | 10.1 | 6.5 |
| Rev Growth 5Y % | 40.1 | 8.4 |
| D/E | 2.6 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.12
$1.08 – $1.16
|
40 B | 1 |
| FY2029 |
$1.01
$0.97 – $1.04
|
39 B | 1 |
| FY2028 |
$0.88
$0.85 – $0.91
|
37 B | 1 |
Key Takeaways
Revenue grew 40.14% annually over 5 years — strong growth
Earnings grew 20.11% over the past year
ROE of 47.67% indicates high profitability
Debt/Equity of 2.62 — high leverage
Generating 3.09B in free cash flow
P/E of 6.50 — trading at a low valuation
Growth
Revenue Growth (5Y)
40.14%
Revenue (1Y)1.59%
Earnings (1Y)20.11%
FCF Growth (3Y)52.98%
Quality
Return on Equity
47.67%
ROIC13.11%
Net Margin10.06%
Op. Margin14.73%
Safety
Debt / Equity
2.62
Current Ratio0.70
Interest Coverage6.88
Valuation
P/E Ratio
6.50
P/B Ratio2.81
EV/EBITDA7.03
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.59% | Revenue Growth (3Y) | 5.23% |
| Earnings Growth (1Y) | 20.11% | Earnings Growth (3Y) | 11.17% |
| Revenue Growth (5Y) | 40.14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 32.61B | Net Income (TTM) | 3.28B |
| ROE | 47.67% | ROA | 7.65% |
| Gross Margin | 21.39% | Operating Margin | 14.73% |
| Net Margin | 10.06% | Free Cash Flow (TTM) | 3.09B |
| ROIC | 13.11% | FCF Growth (3Y) | 52.98% |
| Safety | |||
| Debt / Equity | 2.62 | Current Ratio | 0.70 |
| Interest Coverage | 6.88 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 6.50 | P/B Ratio | 2.81 |
| P/S Ratio | 0.65 | PEG Ratio | 0.41 |
| EV/EBITDA | 7.03 | Dividend Yield | 0.02% |
| Market Cap | 21.32B | Enterprise Value | 33.78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 32.61B | 32.10B | 29.45B | 23.07B | 8.46B |
| Net Income | 3.28B | 2.73B | 2.66B | 431.00M | -2.93B |
| EPS (Diluted) | 0.68 | 0.60 | 0.51 | 0.06 | -0.59 |
| Gross Profit | 6.98B | 7.58B | 6.70B | 5.36B | 164.00M |
| Operating Income | 4.80B | 4.28B | 3.51B | 1.28B | -2.77B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 42.90B | 43.80B | 37.68B | 39.30B | 34.41B |
| Total Liabilities | 35.30B | 37.63B | 34.40B | 37.28B | 33.56B |
| Shareholders' Equity | 7.60B | 6.17B | 3.27B | 2.02B | 840.00M |
| Total Debt | 19.89B | 17.35B | 16.08B | 19.98B | 19.61B |
| Cash & Equivalents | 7.43B | 8.19B | 5.44B | 9.20B | 7.89B |
| Current Assets | 13.02B | 15.19B | 10.70B | 13.24B | 10.55B |
| Current Liabilities | 18.57B | 19.36B | 16.98B | 16.66B | 13.28B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#17 of 670
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026